Literature DB >> 2044731

Methacholine responsiveness, respiratory symptoms and pulmonary function in aluminum potroom workers.

J Kongerud1, V Søyseth.   

Abstract

The relationship between nonspecific bronchial reactivity and work-related asthmatic symptoms was examined in a cross-sectional study of 337 aluminium potroom workers by a shortened method of continuous methacholine nebulization. The provocative concentration producing a 20% fall in forced expiratory volume in one second (FEV1) (PC20) was less than or equal to 8 mg.ml-1 (hyperresponsiveness) in 17 workers (5%), whilst minor responsiveness (8 mg.ml-1 less than PC20 less than 32 mg.ml-1) was present in 24 subjects (7%). The prevalence of work-related asthmatic symptoms was 9%. Female sex, ex-smoker and airflow limitation were significant predictors of methacholine responsiveness (p less than 0.05). In a multiple logistic regression analysis the odds ratios (OR) for work-related asthmatic symptoms was 10.8 (95% confidence interval: 2.9-40.6) for hyperresponsiveness and 4.4 (95% confidence interval: 1.2-16.4) for minor responsiveness. The sensitivity, specificity and predictivity of PC20 less than 32 mg.ml-1 for work-related asthmatic symptoms were 35, 92 and 35%, respectively, whilst the agreement, when adjusted for the by chance expectation, was 0.27 (95% confidence interval: 0.10-0.54). Although a significant association was found between bronchial reactivity and work-related asthmatic symptoms, the usefulness of the methacholine test as a tool for detection of work-related asthmatic symptoms appears to be of limited value due to its low sensitivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044731

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Lack of combined effects of exposure and smoking on respiratory health in aluminium potroom workers.

Authors:  K Radon; D Nowak; D Szadkowski
Journal:  Occup Environ Med       Date:  1999-07       Impact factor: 4.402

2.  Assessing individual employee risk factors for occupational asthma in primary aluminium smelting.

Authors:  C G Barnard; D I McBride; H M Firth; G P Herbison
Journal:  Occup Environ Med       Date:  2004-07       Impact factor: 4.402

3.  Serial measurements of peak expiratory flow and responsiveness to methacholine in the diagnosis of aluminium potroom asthma.

Authors:  J Kongerud; V Søyseth; S Burge
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

4.  Blue-collar work and women's health: A systematic review of the evidence from 1990 to 2015.

Authors:  Holly Elser; April M Falconi; Michelle Bass; Mark R Cullen
Journal:  SSM Popul Health       Date:  2018-08-18

5.  Bronchial responsiveness decreases in relocated aluminum potroom workers compared with workers who continue their potroom exposure.

Authors:  V Søyseth; J Kongerud; O O Aalen; G Botten; J Boe
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

6.  Relation between exposure to fluoride and bronchial responsiveness in aluminium potroom workers with work-related asthma-like symptoms.

Authors:  V Søyseth; J Kongerud; J Ekstrand; J Boe
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

7.  Airway inflammation in aluminium potroom asthma.

Authors:  T Sjåheim; T S Halstensen; M B Lund; Ø Bjørtuft; P A Drabløs; D Malterud; J Kongerud
Journal:  Occup Environ Med       Date:  2004-09       Impact factor: 4.402

8.  Allergy to methyltetrahydrophthalic anhydride in epoxy resin workers.

Authors:  J Nielsen; H Welinder; V Horstmann; S Skerfving
Journal:  Br J Ind Med       Date:  1992-11

9.  Bronchial responsiveness, eosinophilia, and short term exposure to air pollution.

Authors:  V Søyseth; J Kongerud; P Broen; P Lilleng; J Boe
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

10.  Increased neutrophil chemotactic activity is noted in alminum-induced occupational asthma.

Authors:  H S Park; S T Uh; C S Park
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.